CANTUZUMAB RAVTANSINE
UNII RNQ8JQ4R9P

Substance Identification & Data

This profile provides standardized clinical and technical data for Cantuzumab Ravtansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RNQ8JQ4R9P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 868747-45-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RNQ8JQ4R9P

CAS Registry Number

868747-45-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CANTUZUMAB RAVTANSINE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C61576

National Cancer Institute reference terminology for clinical and research data.

INN ID

9441

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-114

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cantuzumab Ravtansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CANTUZUMAB RAVTANSINE

Common Names & Synonyms

CANTUZUMAB RAVTANSINE [INN]

CANTUZUMAB RAVTANSINE [USAN]

CANTUZUMAB RAVTANSINE [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(MUCIN CANAG) (HUMAN-MOUSE MONOCLONAL C242 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C242 LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(4-((3-CARBOXYPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE